ConductScience.org, home

Paper23948935

RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice.

Zhang C and 6 others. J Alzheimers Dis, 2014. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice. Papers, record 23948935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23948935

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice.
PubMed
Journal
J Alzheimers Dis
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
2.57
iCite
Revised in PubMed
2022-04-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang CCong
2Cheng YYufang
3Wang HHaitao
4Wang CChuang
5Wilson SPSteven P
6Xu JJiangping
7Zhang HTHan-Ting

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amyloid beta-PeptidesMajor topic
Cyclic Nucleotide Phosphodiesterases, Type 4Major topic
Gene Expression RegulationMajor topic
Memory DisordersMajor topic
Peptide FragmentsMajor topic
RNA InterferenceMajor topic
Animals
Cyclic AMP
Disease Models, Animal
Exploratory Behavior
Hippocampus
Male
Maze Learning
Mice
Mice, Inbred ICR
Reaction Time
Recognition, Psychology

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AG031687NIA NIH HHSUnited StatesR21AG031687PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
40558524Age-Related Increases in PDE11A4 Protein Expression Trigger Liquid-Liquid Phase Separation (LLPS) of the Enzyme That Can Be Reversed by PDE11A4 Small Molecule Inhibitors.Cells2025https://conductscience.org/library/papers/40558524PubMed
40243652The Impact of the Exposome on Alzheimer's Disease: The Influence of Nutrition.Int J Mol Sci2025https://conductscience.org/library/papers/40243652PubMed
40081105Cyclic nucleotide phosphodiesterases as drug targets.Pharmacol Rev2025https://conductscience.org/library/papers/40081105PubMed
39921664Inhibition of PDE4B ameliorates cognitive defects in the model of alcoholic dementia in 3xTg-AD mice via PDE4B/cAMP/PKA signaling.Int J Neuropsychopharmacol2025https://conductscience.org/library/papers/39921664PubMed
39897494Phosphodiesterase 4 inhibition as a novel treatment for stroke.PeerJ2025https://conductscience.org/library/papers/39897494PubMed
39861162Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer's Disease: A Metabolomic and Proteomic Approach.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/39861162PubMed
39808238Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease.Inflammopharmacology2025https://conductscience.org/library/papers/39808238PubMed
38860393Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases.Zhejiang Da Xue Xue Bao Yi Xue Ban2024https://conductscience.org/library/papers/38860393PubMed
38114603Allosteric inhibition of phosphodiesterase 4D induces biphasic memory-enhancing effects associated with learning-activated signaling pathways.Psychopharmacology (Berl)2024https://conductscience.org/library/papers/38114603PubMed
37572526Biologic that disrupts PDE11A4 homodimerization in hippocampus CA1 reverses age-related cognitive decline of social memories in mice.Neurobiol Aging2023https://conductscience.org/library/papers/37572526PubMed
37490542Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling.Int J Neuropsychopharmacol2023https://conductscience.org/library/papers/37490542PubMed
37306762Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology.Cell Mol Life Sci2023https://conductscience.org/library/papers/37306762PubMed
36073342Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.Aging Cell2022https://conductscience.org/library/papers/36073342PubMed
35156776Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice.CNS Neurosci Ther2022https://conductscience.org/library/papers/35156776PubMed
34790800MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway.Ann Transl Med2021https://conductscience.org/library/papers/34790800PubMed
34539384Phosphodiesterase-4D Knockdown in the Prefrontal Cortex Alleviates Memory Deficits and Synaptic Failure in Mouse Model of Alzheimer's Disease.Front Aging Neurosci2021https://conductscience.org/library/papers/34539384PubMed
34531546Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.Acta Pharmacol Sin2021https://conductscience.org/library/papers/34531546PubMed
34093124CircRNA-ceRNA Network Revealing the Potential Regulatory Roles of CircRNA in Alzheimer's Disease Involved the cGMP-PKG Signal Pathway.Front Mol Neurosci2021https://conductscience.org/library/papers/34093124PubMed
32849849Phosphodiesterase 4D Gene Modifies the Functional Network of Patients With Mild Cognitive Impairment and Alzheimer's Disease.Front Genet2020https://conductscience.org/library/papers/32849849PubMed
32784895Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior.Int J Mol Sci2020https://conductscience.org/library/papers/32784895PubMed

See all 45 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23948935

GET https://conductscience.org/api/papers/v1/23948935/cited_by?page=2